This viewpoint examines obesity therapies' roles in enhancing cancer treatment and survivorship, suggesting greater integration for improved outcomes.
This Viewpoint examines the underutilization of glucagon-like peptide-1 receptor agonists and bariatric surgery in survivors of cancer.
No takes yet. Share an insight, caveat, or question.
Howard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: